Driton Vllasaliu - Search Results

Year	Number of Results
2010	2
2011	2
2012	5
2013	4
2014	4
2015	3
2016	3
2017	2
2018	6
2019	5
2020	6
2021	2
2022	2
2023	2
2024	1

1

Vllasaliu D. Vllasaliu D. Pharmaceutics. 2021 Apr 23;13(5):611. doi: 10.3390/pharmaceutics13050611. Pharmaceutics. 2021. PMID: 33922587 Free PMC article.

2

Exosome-based therapies for mucosal delivery.

Peswani Sajnani SL, Zhang Y, Vllasaliu D. Peswani Sajnani SL, et al. Among authors: vllasaliu d. Int J Pharm. 2021 Oct 25;608:121087. doi: 10.1016/j.ijpharm.2021.121087. Epub 2021 Sep 14. Int J Pharm. 2021. PMID: 34530100 Review.

3

Pulmonary Delivery of Biological Drugs.

Liang W, Pan HW, Vllasaliu D, Lam JKW. Liang W, et al. Among authors: vllasaliu d. Pharmaceutics. 2020 Oct 26;12(11):1025. doi: 10.3390/pharmaceutics12111025. Pharmaceutics. 2020. PMID: 33114726 Free PMC article. Review.

4

Of devices and drugs - Ingestible bots for diagnosis and therapy.

Vllasaliu D, Thanou M. Vllasaliu D, et al. Adv Drug Deliv Rev. 2022 Apr;183:114174. doi: 10.1016/j.addr.2022.114174. Epub 2022 Feb 22. Adv Drug Deliv Rev. 2022. PMID: 35217113 No abstract available.

5

Probing milk extracellular vesicles for intestinal delivery of RNA therapies.

Zhang Y, Belaid M, Luo X, Daci A, Limani R, Mantaj J, Zilbauer M, Nayak K, Vllasaliu D. Zhang Y, et al. Among authors: vllasaliu d. J Nanobiotechnology. 2023 Nov 3;21(1):406. doi: 10.1186/s12951-023-02173-x. J Nanobiotechnology. 2023. PMID: 37924132 Free PMC article.

6

PEGylated nanomedicines: recent progress and remaining concerns.

Vllasaliu D, Fowler R, Stolnik S. Vllasaliu D, et al. Expert Opin Drug Deliv. 2014 Jan;11(1):139-54. doi: 10.1517/17425247.2014.866651. Epub 2013 Dec 3. Expert Opin Drug Deliv. 2014. PMID: 24295065 Review.

7

Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery.

Vllasaliu D, Thanou M, Stolnik S, Fowler R. Vllasaliu D, et al. Expert Opin Drug Deliv. 2018 Aug;15(8):759-770. doi: 10.1080/17425247.2018.1504017. Epub 2018 Jul 27. Expert Opin Drug Deliv. 2018. PMID: 30033780 Review.

8

Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease.

Zhang Y, Thanou M, Vllasaliu D. Zhang Y, et al. Among authors: vllasaliu d. Eur J Pharm Biopharm. 2020 Oct;155:128-138. doi: 10.1016/j.ejpb.2020.08.017. Epub 2020 Aug 25. Eur J Pharm Biopharm. 2020. PMID: 32853696 Review.

9

Nanoparticle modification in biological media: implications for oral nanomedicines.

Muraleetharan V, Mantaj J, Swedrowska M, Vllasaliu D. Muraleetharan V, et al. Among authors: vllasaliu d. RSC Adv. 2019 Dec 6;9(69):40487-40497. doi: 10.1039/c9ra08403g. eCollection 2019 Dec 3. RSC Adv. 2019. PMID: 35542629 Free PMC article. Review.

10

Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery.

Mašková E, Kubová K, Raimi-Abraham BT, Vllasaliu D, Vohlídalová E, Turánek J, Mašek J. Mašková E, et al. Among authors: vllasaliu d. J Control Release. 2020 Aug 10;324:695-727. doi: 10.1016/j.jconrel.2020.05.045. Epub 2020 May 29. J Control Release. 2020. PMID: 32479845 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

45 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year